Methazolamide is a carbonic anhydrase inhibitor with Ki of 50 nM, 14 nM and 36 nM for hCA I, hCA II and bCA IV isoforms, respectively.
Methazolamide is a carbonic anhydrase inhibitor with Ki of 50 nM, 14 nM and 36 nM for hCA I, hCA II and bCA IV isoforms, respectively.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Nicky Konstantopoulos,et al. Methazolamide Is a New Hepatic Insulin Sensitizer That Lowers Blood Glucose In Vivo. Diabetes. 2012 Aug; 61(8): 2146–2154. Published online 2012 Jul 17. doi: 10.2337/db11-0578.
[2] Nam Kyun Koo, Yu Cheol Kim. A Case of Paclitaxel-induced Maculopathy Treated with Methazolamide. Korean J Ophthalmol. 2012 Oct; 26(5): 394–397. Published online 2012 Sep 24. doi: 10.3341/kjo.2012.26.5.394.
分子式 C5H8N4O3S2 |
分子量 236.27 |
CAS号 554-57-4 |
储存方式 -20 ℃长期冷藏储存。冰袋运输 |
溶剂(常温) |
DMSO 52 mg/mL |
Water <1 mg/mL |
Ethanol 6 mg/mL |
体内溶解度
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们